Belimumab 10 mg/kg vs placebo
Participants with one or more serious infections · people with active systemic lupus erythematosus (but not active nephritis or active central nervous system involvement)
Belimumab 10 mg/kg showed no clear difference in participants with one or more serious infections compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.01 [0.66, 1.54]4 studies · 2185 participantsModerate